Literature DB >> 23998067

Chronic lymphoproliferative disorders at an Indian tertiary cancer centre - the panel sufficiency in the diagnosis of chronic lymphocytic leukaemia.

Geeta V Patil Okaly1, Ashwini R Nargund, Venkataswamy E, Prashanth K Jayanna, Chandra Rao Juvva, Shilpa Prabhudesai.   

Abstract

BACKGROUND: Flow cytometry has come to occupy the vanguard of the high through put diagnostic techniques that have been used to differentiate between various chronic lymphoproliferative disorders (CLPD). However, economic considerations have created the need for minimal consensus panels that can yield maximum information at reasonable costs. AIMS: To collect, analyse and correlate the morphologic, immunophenotypic, and the cytogenetic data from the cases of chronic lymphoproliferative disorders, which were diagnosed at an Indian speciality cancer centre. METHODS AND MATERIAL: The morphology was recorded after staining the samples with the Leishman or the MGG stains. The lineage assignment was done by using three colour flow cytometry with a primary panel of antibodies. For the cytogenetic studies, the short term culture of the sample cells were arrested by using colcemid and they were G-banded by using trypsin and Giemsa stain. FISH studies were conducted by using a CLL-specific diagnostic kit. RESULTS AND
CONCLUSIONS: A total of 66 cases were evaluated, which had a median age of 64.5 years and a sex ratio of 2.3:1. Of these 66 cases, 40 cases were of CLL and 9 cases were of atypical CLL. 17 cases were classified as CLPD and these included 13 cases of Non-Hodgkin's Lymphoma, two cases of Hairy Cell Leukaemia, one case of Follicular Lymphoma and one case of Prolymphocytic Leukaemia. In immunophenotyping, the lack of expression of CD22 had the highest correlation with a definitive diagnosis of CLL. Cytogenetics demonstrated a classical follicular lymphoma abnormality, t (14; 18) (q32; q21), in one case. A basic minimal panel is sufficient for the routine diagnosis of CLL. However, the stratification of CLPD requires the use of more extensive panels.

Entities:  

Keywords:  Chronic Lymphocytic Leukaemia (CLL); Chronic Lymphoproliferative Disorders (CLPD); Immunophenotyping; Tertiary Cancer Centre

Year:  2013        PMID: 23998067      PMCID: PMC3749637          DOI: 10.7860/JCDR/2013/5088.3130

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  23 in total

1.  Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.

Authors:  Julio Delgado; Estella Matutes; Alison M Morilla; Ricardo M Morilla; Kwasi A Owusu-Ankomah; Furheen Rafiq-Mohammed; Ilaria del Giudice; Daniel Catovsky
Journal:  Am J Clin Pathol       Date:  2003-11       Impact factor: 2.493

2.  Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).

Authors:  Sara A Monaghan; LoAnn C Peterson; Cathy James; Laura Marszalek; Adela Khoong; Dina J Bachta; William J Karpus; Charles L Goolsby
Journal:  Cytometry B Clin Cytom       Date:  2003-11       Impact factor: 3.058

Review 3.  Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia.

Authors:  S Stilgenbauer; K Döhner; M Bentz; P Lichter; H Döhner
Journal:  Ann Hematol       Date:  1998 Mar-Apr       Impact factor: 3.673

4.  Cytogenetics of lymphomas: a brief review of its theoretical and practical significance.

Authors:  L R Donner
Journal:  Cancer Genet Cytogenet       Date:  1997-03

5.  Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India.

Authors:  Ajay Gogia; Atul Sharma; Vinod Raina; Lalit Kumar; Sreenivas Vishnubhatla; Ritu Gupta; Rajive Kumar
Journal:  Leuk Lymphoma       Date:  2012-05-21

6.  CD23 expression in follicular lymphoma: clinicopathologic correlations.

Authors:  Horatiu Olteanu; Timothy S Fenske; Alexandra M Harrington; Aniko Szabo; Peng He; Steven H Kroft
Journal:  Am J Clin Pathol       Date:  2011-01       Impact factor: 2.493

7.  Immunophenotyping of acute lymphoblastic leukemia in pediatric patients by three-color flow cytometric analysis.

Authors:  P Tiensiwakul; T Lertlum; I Nuchprayoon; P Seksarn
Journal:  Asian Pac J Allergy Immunol       Date:  1999-03       Impact factor: 2.310

8.  Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL).

Authors:  Anna Panovská; Michael Doubek; Yvona Brychtová; Jirí Mayer
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-08

9.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

10.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

View more
  2 in total

1.  Optimal panel of immunohistochemistry for the diagnosis of B-cell non-Hodgkin lymphoma using bone marrow biopsy: a tertiary care center study.

Authors:  Nisha Marwah; Manali Satiza; Niti Dalal; Sudhir Atri; Monika Gupta; Sunita Singh; Rajeev Sen
Journal:  Blood Res       Date:  2021-03-31

2.  Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.

Authors:  Rossana Villegas Gracia; Catalina Franco Alzate; Javier Rendón Henao; José Domingo Torres Hernández; Patricia Elena Jaramillo Arbelaez
Journal:  Colomb Med (Cali)       Date:  2016-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.